To include your compound in the COVID-19 Resource Center, submit it here.

Nulojix approved to prevent organ rejection

FDA approved a BLA from Bristol-Myers Squibb Co. (NYSE:BMY) for Nulojix belatacept

Read the full 129 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE